Bristol-Myers Squibb

The Tale of 2 Drug Handbacks
Motley Fool
Mon, 07/18/11 - 05:33 pm
Exelixis
Bristol-Myers Squibb
cabozantinib
XL-281
Is Brain Swelling Common To Alzheimer’s Drugs?
Pharmalot
Mon, 07/18/11 - 12:55 pm
Alzheimer's disease
Bristol-Myers Squibb
What's in Store for Bristol Myers Squibb at Dapagliflozin FDA Hearing
Seeking Alpha
Mon, 07/18/11 - 09:49 am
FDA
Dapagliflozin
Bristol-Myers Squibb
diabetes
advisory panels
FDA Cites Risks in Diabetes Drug
Motley Fool
Sun, 07/17/11 - 12:04 pm
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis
Seeking Alpha
Sat, 07/16/11 - 11:45 am
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Pfizer
Sanofi
FDA Says Bristol-AstraZeneca Diabetes Drug May Cause Cancer
Bloomberg
Fri, 07/15/11 - 02:21 pm
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
bladder cancer
Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Seeking Alpha
Fri, 07/15/11 - 01:01 am
Bristol-Myers Squibb
Dapagliflozin
FDA
advisory panels
diabetes
Bristol-Myers Inks Oncology Deal
Yahoo/Zacks
Sat, 07/9/11 - 11:18 am
Bristol-Myers Squibb
Innate Pharma S.A.
5 Pharmaceutical Titans Offering Substantial Dividends
Seeking Alpha
Fri, 07/8/11 - 12:03 pm
Abbott Laboratories
Bristol-Myers Squibb
JNJ
Eli Lilly
Mylan
Pfizer
dividends
Potential Dividend Growth for 5 Large Pharmaceutical Companies: 2011 to 2015
Seeking Alpha
Tue, 07/5/11 - 09:58 pm
dividends
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
Seeking Alpha
Tue, 07/5/11 - 04:37 pm
innovation
Eli Lilly
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Seattle Genetics
Bristol-Myers Squibb
JNJ
advisory panels
FDA
Transcept
AstraZeneca
GSK
Human Genome Sciences
Merck
Theravance
Amgen
Biogen Idec
Acorda Therapeutics
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
FDA
Bristol-Myers Squibb
AstraZeneca
Pfizer
Incyte
Novartis
ruxolitinib
Apixaban
Dapagliflozin
6 Healthcare Companies With July Catalysts
Seeking Alpha
Thu, 06/30/11 - 07:26 pm
Alexa
AstraZeneca
Bristol-Myers Squibb
JNJ
Seattle Genetics
Transcept
Johnson & Johnson/Gilead Deal Could Yield More Combinations in HIV
Seeking Alpha
Thu, 06/30/11 - 04:30 pm
Pfizer
Merck
JNJ
HIV
GSK
Gilead Sciences
Bristol-Myers Squibb
Abbott Laboratories
Bristol-Myers signs deal to expand HIV drug access
Yahoo/AP
Tue, 06/28/11 - 11:28 pm
HIV
Bristol-Myers Squibb
Reyataz
generics
Matrixx
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Mon, 06/27/11 - 05:53 pm
Brilinta
AstraZeneca
aspirin
Plavix
Sanofi
Bristol-Myers Squibb
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Mon, 06/27/11 - 05:44 pm
Pfizer
Cel-Sci
Bristol-Myers Squibb
Eliquis
Multikine
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sun, 06/26/11 - 12:09 pm
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
diabetes
Bristol-Myers Experimental Diabetes Drug Safe After 2 Years, Study Shows
Bloomberg
Sat, 06/25/11 - 08:44 pm
Bristol-Myers Squibb
AstraZeneca

Pages